Kuhn & Co Investment Counsel’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$234K Buy
599
+3
+0.5% +$1.27K 0.14% 135
2026
Q1
$282K Hold
596
0.18% 113
2025
Q4
$278K Buy
596
+5
+0.8% +$2.32K 0.19% 117
2025
Q3
$252K Sell
591
-5
-0.8% -$1.94K 0.2% 111
2025
Q2
$228K Buy
596
+3
+0.5% +$1.08K 0.17% 125
2025
Q1
$205K Buy
+593
New +$191K 0.17% 125
2024
Q4
Sell
-591
Closed -$240K 129
2024
Q3
$240K Buy
+591
New +$216K 0.2% 119

Other funds holding HCA

Kuhn & Co Investment Counsel's HCA Position: Q2 2026 in Review

Kuhn & Co Investment Counsel increased its HCA Healthcare (HCA) stake by 0.5% in Q2 2026, buying an estimated $1.27K and bringing the position to 599 shares worth $234K. The position accounts for 0.14% of the portfolio, ranked #135.

Kuhn & Co Investment Counsel first reported a position in HCA in Q3 2024 and has held it in 7 quarters since. The position peaked at $282K in Q1 2026. 519 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Kuhn & Co Investment Counsel held 599 shares of HCA Healthcare worth $234K as of Q2 2026.
  • Kuhn & Co Investment Counsel bought 3 HCA Healthcare shares in Q2 2026, an estimated $1.27K.
  • HCA Healthcare made up 0.14% of Kuhn & Co Investment Counsel's portfolio in Q2 2026, its #135 holding.
  • Kuhn & Co Investment Counsel first reported a position in HCA Healthcare in Q3 2024 and has held it in 7 quarters since.
  • Kuhn & Co Investment Counsel's HCA Healthcare position peaked at $282K in Q1 2026.
  • 519 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Kuhn & Co Investment Counsel's 13F filing for Q2 2026, filed 31 Jul 2026.